Skip to main content
. 2011 Dec 5;11:507. doi: 10.1186/1471-2407-11-507

Figure 3.

Figure 3

Association between biomarkers for prostate cancer detection and TMPRSS2-ERG gene fusion. Gene expression of TDRD1 (A) and CRISP3 (B) in 48 benign, 47 tumor (left side) as well as in the TMPRSS2-ERG (20 fusion-negative vs. 17 fusion-positive tumor samples; right side).